#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma recurrent Ataxia telangiectasia Wiskott-Aldrich syndrome Blastic plasmacytoid dendritic cell neoplasia Cervix carcinoma Mucous membrane pemphigoid Arrhythmia Phaeochromocytoma Neuroendocrine cell hyperplasia of infancy Adrenocortical carcinoma Superficial vein thrombosis Angiosarcoma Chemical burn Small cell lung cancer limited stage Adenocarcinoma gastric More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour Myelodysplastic syndrome with excess blasts – Trials in Disease Mastocytosis – Diagnostics Prolymphocytic leukaemia Hyperoxaluria – Diagnostics Mucopolysaccharidosis I – Diagnostics Activated PI3 kinase delta syndrome Glycogen storage disease type II – Trials in Disease Chronic granulomatous disease – Treatment Idiopathic pulmonary fibrosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Brepocitinib Tosilate Odronextamab 64CU-PSMA I&T Pemafibrate Rezafungin Acetate Dexchlorpheniramine Cilastatin Sodium AMODIAQUINE Tadalafil Tofacitinib Citrate Ethinylestradiol Ampicillin Lisocabtagene Maraleucel Temocillin Rbl007.2 Lomustine TTX-381 Eptinezumab TEDUGLUTIDE LY3372993 More therapies…

    Learn about Your Condition

    Metastases to rectum Bone marrow failure Meniscus operation Adenocarcinoma Splenic marginal zone lymphoma Cardiac ventricular thrombosis Febrile neutropenia Muscular dystrophy Primary hyperoxaluria Skin angiosarcoma Eclampsia Autoimmune disorder Allergic respiratory disease Type 2 diabetes mellitus Oesophageal food impaction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Faceland Clinics, location Rotterdam Binnenrotte

Faceland Clinics, location Rotterdam Binnenrotte

Binnenrotte 113-115, Rotterdam, 3011 HB, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing the Effectiveness and Safety of Botulinum Toxin Type A Products for Treating Frown Lines in Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    • Botulinum Toxin Type A
    • Botulinum Toxin Type A – Haemagglutinin Complex
    The Netherlands

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!